Toggle light / dark theme

How Laughter Yoga Heals, Plus 6 Fun Exercises to Try

As I lie on a wooden floor stretched out in Savasana (Corpse Pose), my mind is calm after an hour of vigorous exercise and deep breathing. The people around me are still and the room is quiet, save for the sounds of slow, gentle inhalation and exhalation. It could be the final moments of any yoga class. But then the man next to me suddenly lets out a thunderous guffaw. Across the room, a woman giggles in response. Soon the entire room is alive with sound—chortles and chuckles, hearty laughs and howling hoots. It’s not any class. It’s Laughter Yoga.

New Stem Cell Therapy for COVID-19 Patients Is Successful

Three critically ill patients at Baptist Hospital in Miami were the first in the U.S. to be successfully treated with stem cells.

The patients were suffering from acute respiratory distress syndrome, or ARDS, and doctors infused them intravenously with cells derived from the lining of umbilical cords.

These are called mesenchymal stem cells and within days after the infusion, the patients who needed 100% oxygen on ventilator support, saw their requirement slashed in half. This significant reduction was also accompanied by a drop in inflammatory markers, meaning that the harmful inflammation crippling the lungs was not only arrested but reversed, according to Baptist Health South

Denver health officials order coronavirus closure of U.S. Postal Service facility serving millions in Colorado, Wyoming

Denver Department of Public Health and Environment issued the order Thursday, the day after investigators said they were denied full access to the facility.


Denver health officials have ordered the closure of a United States Postal Service distribution center that handles all mail for Colorado and Wyoming, saying the facility has multiple confirmed cases of the coronavirus among its employees.

Breakthrough in Stem Cell Research Shows Promise for Treating Multiple Sclerosis

A research study in mice by investigators at the University of Rochester Medical Center (URMC) suggests it would be possible to repair the brain cell damage caused by multiple sclerosis (MS). The research was published in the journal Cell Reports.

The research, led by Steve Goldman, professor of Neurology and Neuroscience at URMC and co-director of the Center for Translational Neuromedicine, manipulated embryonic and induced pluripotent stem cells to create glia, a type of brain cell. Glial progenitor cells, a subtype of these cells, eventually form the primary support cells of the brain, astrocytes and oligodendrocytes, which play essential roles in the health and signaling behavior of nerve cells.

MS is an autoimmune disorder where the body’s immune system attacks oligodendrocytes. Oligodendrocytes manufacture myelin, which makes the insulation that allows nerve cells to communicate with each other. As myelin decreases in MS, the signaling between nerve cells is interrupted, which causes the loss of function that leads to problems with sensation, motor function and cognitive problems.

Interaction between microbiota and immunity in health and disease

The interplay between the commensal microbiota and the mammalian immune system development and function includes multifold interactions in homeostasis and disease. The microbiome plays critical roles in the training and development of major components of the host’s innate and adaptive immune system, while the immune system orchestrates the maintenance of key features of host-microbe symbiosis. In a genetically susceptible host, imbalances in microbiota-immunity interactions under defined environmental contexts are believed to contribute to the pathogenesis of a multitude of immune-mediated disorders. Here, we review features of microbiome-immunity crosstalk and their roles in health and disease, while providing examples of molecular mechanisms orchestrating these interactions in the intestine and extra-intestinal organs. We highlight aspects of the current knowledge, challenges and limitations in achieving causal understanding of host immune-microbiome interactions, as well as their impact on immune-mediated diseases, and discuss how these insights may translate towards future development of microbiome-targeted therapeutic interventions.

/* */